Indoco Remedies Ltd share price logo

Indoco Remedies Share Price

NSE: INDOCO

BSE: 532612

Small Cap

Healthcare Sector

₹301.75

+1.95

(+0.65%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Indoco Remedies Stock Performance

as on September 18, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹299.8
    ₹307.5
    downward going graph

    0.65%

    Downside

    1.91%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹190
    ₹383
    downward going graph

    37.03%

    Downside

    26.93%

    Upside

    downward going graph

Indoco Remedies share price movements today

Previous Close
₹299.80
Open
₹299.80
Volume
1.24L
Upper Circuit
₹359.75
Lower Circuit
₹239.85
Day's Low - High
₹299.8 - ₹307.5
52 Week Low - High
₹190 - ₹383

Indoco Remedies Historical Returns

1 Month Return
+ 2.18 %
3 Month Return
+ 6.01 %
1 Year Return
-18.99 %
3 Year Return
-14.21 %
5 Year Return
+ 11.1 %

Indoco Remedies Fundamentals

as on September 18, 2025 at 4:01 pm IST

Market Cap

₹2,765.59 Cr

Return on Equity (ROE)

-0.89

PE Ratio (TTM)

-23.81

Return on capital employed (ROCE)

2.68

Industry PE ratio

42.21

Beta (LTM)

0.81

P/B Ratio

1.95

Dividend Yield

0.09

PEG Ratio

1.15

Quarterly Earnings Growth YOY

-2097.25

EPS (TTM)

-8.45

Sector

Pharmaceuticals

Book Value

110.79

Technical Analysis

Bullish

View Technical Analysis

Indoco Remedies Stock Valuation

as on September 18, 2025 at 4:01 pm IST

Indoco Remedies in the last 5 years

  • Overview

  • Trends

Lowest (-705.32x)

April 24, 2019

Today (-23.81x)

September 17, 2025

Industry (42.21x)

September 17, 2025

Highest (242.71x)

September 6, 2018

LowHigh

Today’s Price to Earnings Ratio: -23.81x

Indoco Remedies Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Indoco Remedies with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Indoco Remedies Ltd image
Indoco Remedies Ltd
SELL2,765.592.22%0.75-781,664
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY36,969.3829.99%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY17,696.6412.03%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA4,682.85-3.9%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY14,797.1744.73%0.672441,515
See all

Analyst Recommendation on Indoco Remedies Stock

Based on 4 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 4 analysts, 50% of analysts recommend a 'SELL' rating for Indoco Remedies. Average target price of ₹260

Source: S&P Global Market Intelligence

Indoco Remedies Share Price Target

Get share price movements and forecasts by analysts on Indoco Remedies.

What analysts predicted

-13.28%DOWNSIDE

Target Price

₹260

Current Price

₹301.75

Analyzed by

4 Analysts

High

₹325

Target

₹260.00

Low

₹207

Indoco Remedies target price ₹260, a slight downside of -13.28% compared to current price of ₹301.75. According to 4 analysts rating.

Source: S&P Global Market Intelligence

Indoco Remedies Stock's Interest Amongst Investors

Investment in Indoco Remedies Ltd Shares on INDmoney has grown by 1422.22% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:1422.22% versus previous 30 day period

Search interest for Indoco Remedies Ltd Stock has increased by 102% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:102% versus previous 30 day period

Indoco Remedies Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
404.95
411.15
428.75
416.81
473.58
458.75
439.08
424.29
430.66
402.45
383.89
429.08
Other Income
0.35
0.36
0.5
0.41
4.43
2.35
22.39
1.03
1.56
1.84
2.02
1.63
Total Income
433.39
399.56
428.66
426.91
486.16
461.77
472.03
432.52
434.22
412.39
392.23
439.52
Expenses
345.19
337.16
363.4
365.33
410.36
404.72
400.77
383.72
392.41
398.52
390.99
420.36
Operating Profit
59.76
73.99
65.35
51.48
63.22
54.03
38.31
40.57
38.25
3.93
-7.1
8.72
Operating Profit Margin %
14.76%
18%
15.24%
12.35%
13.35%
11.78%
8.73%
9.56%
8.88%
0.98%
-1.85%
2.03%
Profit Before Interest, Tax and Depreciation
88.2
62.4
65.26
61.58
75.8
57.05
71.26
48.8
41.81
13.87
1.24
19.16
Interest
5.25
7.01
8.64
7.79
8.11
10.07
12.05
14.31
17.83
16.11
17.98
26.12
Depreciation
15.65
17.17
17.69
19.88
21.41
24.35
26.23
27.52
28.82
28.72
28.78
29.7
Profit Before Tax
67.3
38.22
38.93
33.91
46.28
22.63
32.98
6.97
-4.84
-30.96
-45.52
-36.66
Tax Paid
17.57
10.07
13.12
9.73
11.04
7.07
10.95
5.15
5.17
-2.56
-4.18
-0.31
Profit After Tax
49.73
28.15
25.81
24.18
35.24
15.56
22.03
1.82
-10.01
-28.4
-41.34
-36.35
Total Net profit including share of profit / Loss from associate company
49.73
28.15
25.81
24.18
35.24
15.56
22.03
1.82
-10.01
-28.4
-41.34
-36.35
EPS
5.4
3.05
2.8
2.62
3.82
1.69
2.39
0.2
-1.09
-3.08
-4.48
-3.94
Actual EPS
5.4
3.05
2.8
2.62
3.82
1.69
2.39
0.2
-1.09
-3.08
-4.48
-3.94
Adjusted EPS
5.4
3.05
2.8
2.62
3.82
1.69
2.39
0.2
-1.09
-3.08
-4.48
-3.94
Diluted EPS
5.4
3.05
2.8
2.62
3.82
1.69
2.39
0.2
-1.08
-3.08
-4.48
-3.94

Indoco Remedies Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,069.36
1,021.03
942.08
1,079.98
1,218.61
1,503.73
1,640.05
1,788.22
1,641.29
Other Income
3.97
4.69
6.14
2.44
3.12
2.33
2.34
21.38
6.44
Total Income
1,100.74
1,049.99
974.59
1,109.03
1,244.65
1,543.08
1,670.95
1,838.67
1,671.36
Expenses
940.31
910.37
891.79
983.38
1,017.26
1,213.41
1,382.51
1,572.98
1,565.66
Operating Profit
129.05
110.66
50.29
96.6
201.35
290.32
257.54
215.24
75.63
Operating Profit Margin %
12.07%
10.84%
5.34%
8.94%
16.52%
19.31%
15.7%
12.04%
4.61%
Profit Before Interest, Tax and Depreciation
160.43
139.62
82.8
125.65
227.39
329.67
288.44
265.69
105.7
Interest
6.21
23.51
20.54
26.25
22.26
14.14
25.03
38.02
66.23
Depreciation
63.28
67.71
71.57
70.82
73.13
78.96
70.61
91.87
113.84
Profit Before Tax
90.94
48.4
-9.31
28.58
132
236.57
192.8
135.8
-74.37
Tax Paid
13.88
7.24
-6.41
4.46
38.95
81.77
50.55
38.79
3.58
Profit After Tax
77.06
41.16
-2.9
24.12
93.05
154.8
142.25
97.01
-77.95
Total Net profit including share of profit / Loss from associate company
77.06
41.16
-2.9
24.12
93.05
154.8
142.25
97.01
-77.95
EPS
8.36
4.47
-0.32
2.62
10.1
16.8
15.44
10.53
-8.46
Actual EPS
8.36
4.47
-0.32
2.62
10.1
16.8
15.44
10.53
-8.46
Adjusted EPS
8.36
4.47
-0.32
2.62
10.1
16.8
15.44
10.53
-8.46
Diluted EPS
8.36
4.47
-0.32
2.62
10.1
16.8
15.44
10.51
-8.45

Indoco Remedies Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
112.23
88.64
122.72
132.11
122.85
82.22
173.83
178.83
155.39
94.93
Cash Flow from Investing Activities
-13.01
19.02
4.02
-6.81
2.53
10.16
3.91
-0.93
-5.91
17.04
Cash Flow from Financing Activities
-1.61
131.58
-38.77
-16.15
-63.95
-29.87
-44.36
22.81
280.42
241.43
Net Cash Flow
-0.11
49.66
-51.48
12.22
2.97
-14.34
8.05
-6.54
3.93
-2.76

Indoco Remedies Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
58.69%
58.69%
58.73%
58.74%
58.74%
58.72%
58.75%
58.75%
58.8%
58.9%
58.9%
DII
18.07%
17.29%
17.93%
17.78%
19.56%
19.41%
18.67%
18.24%
18.9%
18.75%
18.96%
FII
0.12%
0.12%
0%
1.59%
1.69%
1.91%
1.47%
1.7%
1.25%
1.24%
1.22%
Public
22.01%
21.7%
21.76%
21.88%
20%
19.92%
21.07%
21.28%
21.03%
21.02%
20.83%
Total Outstanding Shares
9,21,50,355
9,21,50,355
9,21,50,355
9,21,50,355
9,21,50,355
9,21,82,205
9,21,82,205
9,21,82,205
9,21,82,205
9,22,47,905
9,22,47,905
Total Shareholders
35,713
34,731
35,431
36,588
32,600
33,201
34,511
34,416
34,676
34,497
33,129

Mutual Funds that own Indoco Remedies Stock

Check out the Mutual Funds with significant holdings in Indoco Remedies.

Indoco Remedies Earnings and Dividends

View detailed summary of the earnings and dividend history of Indoco Remedies.

  • Indoco Remedies Ltd Earnings Results

    Indoco Remedies Ltd’s net profit fell -1466.03% since last year same period to ₹-35.79Cr in the Q1 2025-2026. On a quarterly growth basis, Indoco Remedies Ltd has generated 11.39% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Indoco Remedies Ltd Dividends May,2025

    In the quarter ending March 2025, Indoco Remedies Ltd has declared dividend of ₹0.20 per share on 22 May 2025 - translating a dividend yield of 0.07%.

    Read More about Dividends

Indices Featuring Indoco Remedies Stock

Check stock indices that include Indoco Remedies.

BSE Healthcare

₹45,130.04

0.87 (▲391.31%)

BSE Small-Cap

₹54,532.75

-0.01 (▲-4.28%)

Insights on Indoco Remedies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 392.23 Cr → 439.52 Cr (in ₹), with an average increase of 10.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -40.39 Cr → -35.79 Cr (in ₹), with an average increase of 12.9% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 18.52% to 18.55% in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 10.7% return, outperforming this stock by 29.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 58.90% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.7% return, outperforming this stock by 153.9%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.24% to 1.22% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.02% to 20.83% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, INDOCO stock has moved down by -2.9%

About Indoco Remedies Ltd

Indoco Remedies Limited is a Mumbaibased pharmaceutical company established in 1947 and currently has a presence in 55 countries with a USD 166 million turnover. It mainly focuses on Formulations Finished Dosage Forms and Active Pharmaceutical Ingredients. It is presently active in therapeutic segments, including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and antifungal. It has 9 manufacturing facilities, 6 for FDFs and 3 for APIs, and is supported by a state-of-the-art RD Centre. AC Nielsen ORGMARG market survey ranks Indoco first in stomatology, ninth in opthalmic and 12th in pediatric segments in terms of prescription generation. It has a marketing network of 1248 medical representatives. To further its goals, the company purchased remaining shares of Xtend Industrial Designers and Engineers in 2014, and acquired a Clinical Research Division from Piramal Enterprise in 2015. It likewise incorporated Indoco Remedies Singapore Pte Limited in 2015 and established a 100% subsidiary in Czech Republic in 2019. It has also launched 8 new products, 5 in Cardiac, 2 in Anti-diabetic and 1 in Dermatology. The company is further patent-recognised for products like Olopatadine, Gliclazide, Brinzolamide, Febuxostat, Rufinamide, Lacosamide, Tapentadol, Aminoindane compound and Pyrazole derivatives. It currently has 3 subsidiary companies under its fold, Xtend Industrial Designers and Engineers Pvt. Ltd., Indoco Remedies Czech sro and Indoco Remedies UK Limited.

Revenue: ₹429.08Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-36.35Cr as on June 2025 (Q1 FY26)
Listing date: 14 Jan, 2005
Chairperson Name: Suresh G Kare
OrganisationIndoco Remedies Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOSuresh G Kare
E-voting on sharesClick here to vote

FAQs

What is Indoco Remedies share price today?

Indoco Remedies share price today stands at ₹301.75 as on at the close of the market. Indoco Remedies share today touched a day high of ₹307.5 and a low of ₹299.8.

What is the 52 week high and 52 week low range for Indoco Remedies share?

Indoco Remedies touched a 52 week high of ₹383 and a 52 week low of ₹190. Indoco Remedies share price today i.e. is closed at ₹301.75, which is -21.21% down from its 52 week high and 58.82% up from its 52 week low.

What is Indoco Remedies's market capitalisation today?

Indoco Remedies market capitalisation is ₹2,765.59 Cr as on .

How to buy Indoco Remedies shares?

To buy Indoco Remedies shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for INDOCO or Indoco Remedies Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Indoco Remedies shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Indoco Remedies trading volume today?

Indoco Remedies trading volume is 1.24L as on . This means that 1.24L shares of Indoco Remedies were bought and sold on the stock market during today's trading session.